Frederic Guerard - 21 Mar 2024 Form 3 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Director
Signature
/s/ Evert Schimmelpennink, as Attorney-in-Fact
Issuer symbol
LENZ
Transactions as of
21 Mar 2024
Net transactions value
$0
Form type
3
Filing time
25 Mar 2024, 20:24:55 UTC
Previous filing
27 Mar 2023
Next filing
22 Apr 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney